A B S T R A C T Intact human platelets loaded with "PO, contain multiple phosphorylated proteins. Thrombin treatment of intact "PO-loaded platelets results in a 2-6-fold increase in phosphorylation of a platelet protein (designated "peak 7" protein) of approximately 40,000 mol wt as determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis and by gel filtration on Sephadex G-150. A similar increase in phosphorylation was observed in a platelet protein (designated "peak 9" protein) of approximately 20,000 mol wt. The time for half-maximal phosphorylation of peak 7 and peak 9 protein was 10-14 s. The concentration of thrombin at half-maximal phosphorylation was 0.25 U/ml for both proteins. Prior incubation of platelets with dibutyryl cyclic adenosine 3',5'-monophosphate or prostaglandin E1 inhibited thrombin-induced peak 7 and peak 9 protein phosphorylation. The erythroagglutinating phytohemagglutinin of Phaseolus vulgaris, a non-proteolytic release-inducing agent, induced peak 7 and peak 9 protein phosphorylation. Thus, the characteristics of peak 7 and peak 9 protein phosphorylation are similar to those of the platelet release reaction, suggesting that the phosphorylation of these proteins may play a role in the platelet release reaction.
INTRODUCTION
Evidence has been presented in recent years suggesting that platelet aggregation and the release reaction may be controlled by variations in intracellular adenosine 3',5'-cyclic monophosphate (cAMP)' levels (2) . Thrombin, a potent inducer of the platelet release reaction, has been shown to bind to receptors on the platelet surface (3, 4) and to decrease the activity of platelet adenylate cyclase without a change in phosphodiesterase activity (5) . In other tissues the effects of cAMP are mediated through changes in protein phosphorylation resulting from a cAMP-induced alteration in protein kinase and/ or phosphoprotein phosphatase activity (648). In many tissues increasing cAMP is associated with increased protein kinase activity although recently the opposite response, namely inhibition of protein kinase activity by rising cAMP has also been described (9, 10) . The cAMP-dependent protein kinases are relatively nonspecific, and their physiologically important endogenous substrates have been difficult to identify in cell homogenates (6) . Thus we have studied protein phosphorylation in both intact platelets and platelet homogenates in 'Abbreviations used in this paper: cAMP, adenosine 3',5'-cyclicmonophosphate; DB-cAMP, N-2',O'-dibutyrylcAMP; an attempt to define potential physiologic substrates of the platelet protein kinases.
We report here that thrombin treatment of intact platelets results in a 2-6-fold increase in phosphorylation of two proteins of mol wt 40 ,000 (peak 7) and 20,000 (peak 9) and that agents which elevate intracellular cAMP block this reaction. In disrupted platelets proteins of molecular weight similar to peak 7 and 9 proteins are phosphorylated by [e-_-P]ATP. However, these latter phosphorylation reactions are unaffected by either thrombin or cAMP, suggesting that the normal control Platelet preparation and "P04 loading. Platelets were isolated by differential centrifugation as previously described from fresh EDTA-anticoagulated human blood or f rom acid citrate dextrose-anticoagulated 72-h-old platelet concentrates (for large-scale preparations) beginning with the first 2,250-g centrifugation (15) . The isolation was carried out at room temperature in isotonic phosphate-buffered saline, pH 6.5, containing 0.113 M NaCl, 0.0043 M K2HPO4, 0.0043 M Na2HPO4, 0.0244 M NaH2PO4, and 0.0055 M glucose. The isolated platelets were resuspended at 0.1-1 X 10' platelets/ml in 35 ml isotonic Tris-buffered saline, pH 7.4, containing 0.14 M NaCl, 0.015 M Tris-HCl, and 0.0055 M glucose ("resuspension buffer") and incubated for 15 min to deplete them of phosphate. The platelets were then sedimented at 2,250 g for 15 min at room temperature and resuspended in 35 ml of the same buffer for a further 15-min incubation. The platelets were sedimented again at 2,250 g for 15 min and resuspended in a small volume of resuspension buffer, and the platelet concentration was estimated from the packed cell volume of the platelet suspension by assuming that a 1% packed cell volume equals 1 X 10' platelets/ml (3, 15) . The platelet suspension was adjusted to contain 2 X 10' platelets/ml and 0.5 mCi/ml '3PO4 adjusted to pH 7-7.5 with NaOH. Incubation at room temperature for 60 min served to load the platelets with 'PO4. For most experiments reactions were carried out in a total volume of 0.025-0.125 ml in either 500-,ul polyethylene or 1.5-ml polypropylene microtest tubes (Brinkmann Instruments, Inc., Westbury, N.Y.). Platelets prepared from fresh whole blood were used for most studies of intact platelets, and the use of outdated platelets for a particular experiment is indicated in the text.
Preparation of crude supernate for protein kinase studies. Platelets for protein kinase studies were isolated in isotonic phosphate-buffered saline, pH 6.5, from either fresh blood or 72-h-old platelet concentrations as described above. They were then washed an additional time with resuspension buffer and suspended in the same buffer at a concentration of 20-30 X 10' platelets/ml. The platelet suspension was then frozen in liquid nitrogen and stored at -90'C until a sufficient quantity had been accumulated. To obtain a crude supernatant fraction, the frozen suspensions were thawed at 37'C and sonicated on ice with constant stirring. The particulate fraction was pelleted by centrifugation at 4VC at 48 ,000 g for 30 min. Preliminary experiments showed that approximately three-quarters of the protein kinase activity when assayed with exogenous substrates is in the supernatant fraction after this treatment. Higher yields of supernatant protein kinase activity (as much as twofold higher from equal amounts of platelets) were obtained when the platelets were frozen before sonication than when not frozen but sonicated immediately after isolation. The particulate fraction from platelets frozen before sonication still contained residual protein kinase activity when assayed with exogenous substrates.
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis. Platelets to be fractionated by SDS polyacrylamide gel electrophoresis were solubilized by boiling for 5 min in 2-4%o SDS, 0.1 M 2-mercaptoethanol, and 0.02 M sodium phosphate buffer, pH 7.4, ("SDS buffer"). After boiling in SDS buffer, the samples remained stable for over 30 min at room temperature and could be stored at 4VC for several hours or overnight at -120'C as judged by comparison of the radiochromatograms of SDS gels of fresh and stored samples.
Cylindrical SDS polyacrylamide gel electrophoresis was performed essentially as described by Weber and Osborn (16) . Bromphenol blue in 80% sucrose was added to samples of 5 X 10' solubilized platelets (100 ,ug protein) which were layered on 5%o polyacrylamide gels with 2.3% bisacrylamide and 0.1% SDS in 0.1 M sodium phosphate buffer, pH 7.4, in 10-cm-long, 5-mm inside diameter glass tubes. Electrophoresis was carried out at 8 mA/gel for 3.5 h with buffers of 0.1 M sodium phosphate, pH 7.4, 0.1% SDS containing 0.1 M 2-mercaptoethanol. The gels were stained overnight in 12% trichloroacetic acid, 50% methanol, and 0.03% Coomassie Brilliant Blue R and subsequently destained by diffusion over 24 h in 7% acetic acid, 10% methanol, and 0.85% phosphoric acid. The gels were frozen and divided into 2-mm slices with a razor blade type slicer (Bio-Rad Laboratories), and the slices were assayed for 'PO4 in a liquid scintillation counter after the addition of Bray's solution (17) .
SDS polyacrylamide slab gel electrophoresis was performed by a modification of the methods of Laemmli (18) and of Weber and Osborn (16) in an apparatus similar to that described by Reid and Bielski (19) . The stacking and well-forming gel consisted of 3% acrylamide with 3.2% bisacrylamide and 0.1% SDS in 0.05 M sodium phosphate buffer, pH 6.4. The separating gel and the buffers were the same as described above for the cylindrical gels. Samples of 25-100 ug platelet protein were layered onto the acrylamide in each of the 12 wells of a 2-mm thick analytical slab gel. Electrophoresis was carried out at 30 V until the tracking dye had entered the separating gel and then at 60 V for 3 h. Staining and destaining were performed as for cylindrical gels. The gels were dried on Whatman no. 50 hardened filter paper and exposed to Kodak RP Royal X-Omat medical X-ray film that was subsequently developed with a Kodak RPX-Omat developer. When indicated, the autoradiograph was scanned with a spectrophotometer equipped with linear transport and film holding accessories (Gilford Instrument Laboratories, Inc., Oberlin, Ohio).
Molecular weight determination by SDS polyacrylamide gel electrophoresis (16) employed the following standards: E. coli. p-galactosidase, 130,000; bovine fibrinogen alpha chain, 73,000; bovine serum albumin, 68,000; bovine fibrinogen beta chain, 60,000; bovine fibrinogen gamma chain, 53,000; E. coli alkaline phosphatase subunit, 43,000; rabbit muscle aldolase, 40,000; hog stomach mucosa pepsin, 35,000; the B chain of human a-thrombin, 33,000; and sperm whale myoglobin, 17,200. Partial purification of peak 7 protein by preparative SDS polyacrylamide gel electrophoresis. 3 ml of platelets containing 2 X 109 platelets/ml were incubated with 'PO4 as described above. Thrombin, 1 U/ml, was added to the platelet suspension, and after a 5-min incubation the platelets were solubilized in SDS buffer and the entire volume was electrophoresed in a single well of a 4-mm thick SDS polyacrylamide slab gel. The protein in the region of the gel containing peak 7 protein was eluted as previously described (20) and adjusted to contain 10 mM diisopropyl fluorophosphate (DFP). The solution was lyophilized, dissolved in 1 ml of H20, and then dialyzed for 24 h with one change of dialysis fluid against 500 ml of resuspension buffer containing 0.01% SDS. Single peaks of Coomassie Blue staining and radioactivity with the same mobility as peak 7 protein were seen on SDS polyacrylamide gel electrophoresis of this material, suggesting that it had remained intact during purification. Approximately 40% of peak 7 protein was recovered in the elution step.
Preparation of histone-Sepharose 4B. Histone-Sepharose was prepared as previously described (21) except that after coupling of the histone to the activated Sepharose, the histone-Sepharose was washed with 10 vol of 0.01 M imidazole chloride, 1 M sodium chloride (pH 6), then 10 vol of 0.01 M imidazole chloride, pH 6 , and stored in the same buffer.
Histone-Sepharose affinity chromatography of crude platelet supernate. In a typical small-scale preparation, the supernate from platelets prepared from 2 U fresh plateletrich plasma (4 ml, 2.88 X 105 U protein kinase activity) was diluted to 100 ml with 0.01 M imidazole chloride, pH 6 , and applied to a histone-Sepharose column (bed volume of 25 ml) that had previously been equilibrated with 0.01 M imidazole chloride, pH 6. After loading, the column was washed with 70 ml 0.01 M imidazole chloride, pH 6, and the enzyme fractions were then eluted with a linear 0-0.6 M NaCl gradient in 0.01 M imidazole chloride, pH 6 (total gradient volume was 240 ml). All steps were performed at 4°C. 7-ml fractions were collected. Protein kinase activity with protamine as substrate and cAMP binding activities were determined on each fraction, as described below. For a large-scale preparation, the supernate from platelets prepared from 150 U 72-h-old platelet concentrates (158 ml, 1.31 X 107 U protein kinase activity) was diluted with 4 vol 0.01 M imidazole chloride, pH 6, and chromatographed on a 375-ml-bed volume histoneSepharose affinity column. The total gradient volume was 8 liters. Every fifth fraction (20 ml each) was assayed for protein kinase activity with protamine as substrate.
Pooled fractions of protein kinase after histone-Sepharose chromatography were concentrated by using a DEAEcellulose column equilibrated with 0.01 M imidazole chloride, pH 6, (2.5 X 3 cm for up to 3 X 109 U enzyme activity) at 4°C. The enzyme fraction was loaded onto the column by diluting the histone-Sepharose fraction with 2 vol 0.01 M imidazole chloride, pH 6, in portions as they were applied to the column. After washing with the diluting buffer, the enzyme was eluted by washing the column with 0.01 M imidazole chloride, 1 M NaCl, pH 6. Fractions (2 ml) were collected and analyzed for protein kinase activity. The peak tubes were pooled. This method usually gave a 10-15-fold concentration of activity with a recovery of approximately 80%. No changes in the specific activity of the enzymes were observed.
Preparation of regulatory subunit from rabbit muscle protein kinase. Rabbit muscle cAMP-dependent protein kinase was prepared by a slight change in the modification (21) of a previously described (22) method. The method of Corbin et al. (21) was followed except that a histoneSepharost affinity column was used and the buffer was 0.01 M imidazole chloride-0.001 M EDTA, pH 6. Frozen rabbit muscle was used. The regulatory and catalytic subunits of this protein kinase were then separated by incubation with [3H] cAMP and chromatography on a histone-Sepharose column as described previously (23) where caseinSepharose was used. The regulatory subunit eluted after the catalytic subunit on this column.
Preparation of partially-purified, heat-stable inhibitor of cAMP-dependent protein kinases. The heat-stable inhibitor was prepared as previously described (24) from 1 lb of frozen rabbit muscle. The purification was carried through the trichloroacetic acid precipitation step, subsequent resolubilization, and dialysis.
Determination of molecular weights by Sephadex G-150 chromatography. A 2.5 X 61-cm upward flow Sephadex G-150 column was calibrated by determining the elution volume (V.) of known molecular weight standards: rabbit muscle lactate dehydrogenase, 132,000; bovine serum albumin monomer, 69,000; 12.I-ovalbumin, 45,000; 'I-diisopropyl phosphoryl-thrombin, 37,000; and sperm whale myoglobin, 17,800. Blue Dextran (mol wt > 2 X 106) was used to calculate the void volume (V.), and dinitrophenyl-glycine was utilized to calculate the included volume (V6). The proteins were monitored by their absorbance at 280 nm or by measuring their radioactivity. Dinitrophenyl-glycine was monitored at 410 nm. The radioactive proteins were prepared by the chloramine-T method of Hunter (25) (27) . The filters and precipitates were dissolved in 10 ml Bray's solution (17) and counted in a Packard Tri Carb liquid scintillation spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill. Misccllaneons methods. Platelet suspensions were disrupted by sonication for 15 s on ice with the microprobe of a Biosonik II sonifier set at 70% intensity for volumes less than 3 ml and the standard probe under the same conditions for volumes greater than 3 ml (15) . [14C] Serotonin release studies were performed as previously described, the platelets having been incubated with ["C] serotonin before the phosphate depletion step (3) . Alkaline and acid phosphatase were assayed as described by Lindhardt and Walter (30) . Thrombin was assayed as described by Seegers and Smith (31) . Protein was estimated by the method of Lowry et al. (32) .
RESULTS
Effect of thrombin on protein phosphorylation in intact platelets. In preliminary experiments we determined that the prolonged period required for phosphate depletion (two 15-min incubations) and subsequent loading with 2P04 did not damage the platelets with respect to their ability to undergo thrombin-induced [14C] serotonin release. Shorter periods of phosphate depletion or loading diminished the incorporation of 'PO4 into platelet proteins. While we refer to this process as "phosphate loading," we do not know what changes, if any, occur in intracellular phosphate. Rather, these conditions are those that we found to result in maximal protein labeling in control platelets.
There was prominent protein phosphorylation observed in control 'PO4-loaded platelets as shown in the radiochromatogram of the cylindrical SDS polyacrylamide gel shown in Fig. 1 . 9 radioactive peaks were consistently seen in radiochromatograms of cylindrical gels, while approximately 20 radioactive proteins could be distinguished in the autoradiographs of SDS polvacrylamide slab gels. The increased number of radioactive proteins seen with the latter technique is due to the increased resolution of radioactivity seen on autoradiographs as compared to sliced gels counted in a liquid scintillation counter. When 3PO4-loaded platelets were treated with thrombin, 1 U/ml, for 5 min before boiling in SDS buffer, a different pattern Of 'PO4 incorporation was observed. Either bovine or human thrombin induced a 2-6-fold increase (mean 3.28-fold-+-0.27 SEM, n = 13) in phosphate incorporation into a peak of 'PO4 corresponding to the darkest staining protein band on the SDS polyacrylamide gel. This protein had an apparent molecular weight of 40,000 and was designated "peak 7." A similar increase in phosphorylation (2.84-fold±0. were solubilized and electrophoresed on cylindrical SDS polyacrylamide gels as described in Methods. The radioactivity in each peak was calculated by summing the counts per minute of the three highest fractions in the peak.
SEM, n = 9) was consistently seen in a peak of approximately 20,000 mol wt designated "peak 9." There was no consistent thrombin-induced alteration of 32P04 incorporation into radioactive peaks other than 7 and 9 when the radioactive peaks were examined by either cylindrical or slab SDS polyacrylamide gel electrophoresis. In contrast, thrombin that was inhibited by DFP at its active serine residue, had no effect on the incorporation of "POt into platelet protein.
To examine the possibility that release-inducing agents other than thrombin could initiate platelet protein phosphorylation, we studied the effects of E-PHA (14, 33) on platelets. Exposure of 3"P04-loaded platelets to E-PHA (0.13 mg/ml for 15 min) resulted in a 3.2-fold and 3.9-fold increase in phosphorylation of peak 7 and 9 proteins, respectively. Characterization of peak 7 and peak 9 protein. We initially demonstrated that the radioactivity in peak 7 was covalently bound to protein. 3"POt-loaded platelets were precipitated with cold 10% trichloroacetic acid and then delipidated as described by Cohen et al. (34) . The SDS polyacrylamide gel Coomassie Blue staining and radiochromatogram patterns of the material remaining after lipid extraction were similar to those described above for whole solubilized platelets, suggesting that the radioactivity in peaks 7 and 9 is not associated with phospholipids. When samples of the delipidated trichloroacetic acid precipitate from thrombin-treated platelets were boiled for 15 min in 0.2 M sodium hydroxide we found a 90% loss of 32POt as measured by trichloroacetic acid precipitation. In contrast, treatment in 10% trichloroacetic acid for 15 mmn at 90°C resulted in only 8% hydrolysis of "2PG4. These results are consistent with the stability of phosphomonoesters of serine and threonine (35) and indicate that the phosphate is not incorporated into RNA, which is labile in hot acid (36) .
Partial acid hydrolysis of "PO4-labeled delipidated platelet protein followed by high voltage paper electrophoresis (37) disclosed the presence of labeled phosphoserine and phosphothreonine residues. When corrected for hydrolysis of phosphoserine and phosphothreonine (37) , over 80% of the label was determined to be in the form of phosphoserine.
When peak 7 protein, eluted from a 4-mm thick SDS polyacrylamide gel as described in Methods, was treated with hot alkali or hot acid, results similar to those described above for the delipidated platelet protein were observed. Treatment of peak 7 protein with TPCK trypsin (0.3 mg/ml) for 21 h at 370C, pH 7.4, resulted in a 63% decrease in radioactivity in peak 7 protein and a similar decrease in Coomassie Blue staining upon re-electrophoresis of the protein on SDS gels. Incubation of peak 7 protein for 15 h at 450C, pH 8.0, with E. coli alkaline phosphomonoesterase, 7 U/ml, resulted in 78% loss of radioactivity from peak 7 protein as determined by re-electrophoresis of the protein on SDS gels.
Treatment of the delipidated platelet protein with sodium hydroxide or alkaline phosphatase as described above resulted in a 65 and 73% decrease, respectively, in radioactivity in peak 7 protein as assessed by subsequent SDS polyacrylamide gel electrophoresis of the samples. These experiments indicate that the radioactivity in peak 7 and peak 9 is in the protein in the form of phosphomonoesters of serine and threonine residues.
Effect of thrombin concentration on peak 7 protein and peak 9 protein phosphorylation. The effect of thrombin on peak 7 protein and peak 9 protein phosphorylation was dependent upon thrombin concentration. The thrombin concentration that produced half-maximal phosphorylation was 0.25 U/ml for both peak 7 protein (Fig. 2 ) and peak 9 protein.
Time-course of thrombin-induced peak 7 protein and peak 9 protein phosphorylation. Thrombin had no effect on the phosphorylation of peak 7 protein or peak 9 protein when platelets were disrupted before thrombin treatment (see below). Thus, by lysing the platelets with SDS, we were able to stop the interaction between platelets and thrombin rapidly, allowing us to determine the time-course of the effect of thrombin on peak 7 and peak 9 protein phosphorylation. The effect of thrombin, 1 U/ml, was rapid with the time for half-maximal phosphorylation of peak 7 protein being 10 s (Fig. 3) . The time for half-maximal phosphorylation of peak 9 protein (14 s) was similar (data not shown).
The thrombin concentration curve and the time-course for thrombin-induced phosphorylation of peak 7 and peak 9 proteins were similar to those parameters previously observed for the thrombin-induced platelet release reaction and for the inhibition of platelet adenylate cyclase by thrombin (5, 33, 38, 39) .
Effect of raising intracellular cAMP concentrations on phosphorylation of peak 7 and 9 proteins. PGE1, 1 ,ug/ml, and N6-2',0'-dibutyryl cAMP (DB-cAMP), 1mM, compounds that raise the intracellular cAMP levels in platelets (2) and partially block the thrombininduced release reaction (5, 40), did not alter platelet protein phosphorylation significantly in the absence of thrombin. However, treatment of intact platelets with these agents before the addition of thrombin resulted in a 48 and 53% inhibition, respectively, of peak 7 protein phosphorylation, as estimated from densitometry of the autoradiographs as described in Methods. Similarly, thrombin-induced peak 9 protein phosphorylation was inhibited 55 and 70% by PGE1 and DB-cAMIP, respectively. The inhibition of thrombin-induced peak 7 and peak 9 protein phosphorylation by PGE1 and DB-cAMP is shown in Fig. 4 .
Molecular weight of peak 7 protein by gel filtration. Platelets (70 ml of 4 X 109 platelets/ml) were isolated from 10 U of 72-h-old platelet concentrates, loaded with 0.02 mCi/ml 32P4, and treated with 4 U/ml thrombin.
These platelets retained the ability to aggregate and to release ["C]serotonin when exposed to thrombin. The platelets were sedimented, and the supernate was discarded before sonication of the platelets in 12.5 ml 0.1 mM sodium phosphate buffer, pH 7.4, containing 10 mM DFP. The particulate material was sedimented at 165,000 g X 60 min at 4VC, and 100 mg of the supernatant protein in 10 ml (containing 75% of the total platelet peak 7 protein) was chromatographed at 4VC in 0.1 Ml sodium phosphate buffer, pH 7.4, on a calibrated Sephadex G-150 column as described in Methods. FIGURE 3 Time-course of the effect of thrombin on the phosphorylation of peak 7 protein. 'PO4-loaded platelets were incubated with thrombin (0.76 U/ml) for various times before the reaction was stopped by solubilizing the platelets in SDS. 'PO4 incorporated by peak 7 protein was estimated as described in Fig. 2 . Platelets were loaded with '0PO4 (0.5 mCi/ml) as described in Methods. Gels 1 and 2: no additions; 3 and 4: thrombin, 1 U/ml, for 5 min; 5 and 7: PGE1 alone for 20 min; 6 and 8: PGE1 for 15 min with the addition of thrombin, 1 U/ml, for a further 5 min; 9 and 11: DB-cAMP alone for 20 min; 10 and 12: DB-cAMP for 15 min with the addition of thrombin, 1 U/ml, for a further 5 min. The radioactivity in peak 7 and 9 proteins was assessed from the A500 of the bands on the autoradiograph of an SDS slab gel electrophoresis of the fractions. The peak absorbance of each band was less than 2.0. At these levels the peak absorbance of each band was proportional to the radioactivity of the same band on the SDS polyacrylamide gel as assessed in a liquid scintillation spectrometer.
Three peaks of radioactivity were eluted from the column. The first peak was detected at the void volume, while the third peak eluted just ahead of the included volume. The second peak of radioactivity eluting from the column, subsequently identified as containing peak 7 protein by SDS polyacrylamide gel electrophoresis of the fractions, had an apparent molecular weight of 49,000. This value is similar to the molecular weight of peak 7 protein determined by SDS polyacrylamide gel electrophoresis. Furthermore, the apparent molecular weight of the radioactive protein in peak 7 as determined by SDS polyacrylamide gel electrophoresis was not altered by mercaptoethanol reduction. This suggests that peak 7 Platelet samples (4 X 109/ml) were sonicated and centrifuged to obtain the supernatant fraction where indicated. Endogenous phosphorylation was measured by incubation with 125 OM [Ly-"2P]ATP (244 ,/Ci/mol), 5 mM magnesium acetate-0.5 mM 1-methyl-3-isobutylxanthine for 10 min at 220C.
10-iul portions of each reaction mixture were subjected to SDS polyacrylamide slab gel electrophoresis.
Autoradiograph film exposure 7 h. The autoradiograph and a negative photograph of the stained gel were scanned at 500 nm in a Gilford spectrometer as described in Methods. Units are peak absorbance at 500 nm as described in the legend of Fig. 4 . Results are expressed as the ratio of peak absorbance on the autoradiograph/peak absorbance of a negative photograph of the stained gel.
tion amounted to less than 5% of the total activity and has been subtracted in all activities determined with exogenous substrates reported hereafter. Crude sonicates of fresh platelets contained protein kinase activity that was only slightly stimulated by added cAMP when assayed with protamine as substrate (1.1-1.2-fold) and was stimulated 1.5-fold when histone f2b was used as substrate. After centrifugation at 48,000 g for 30 min, 65-75% of the total protein kinase activity remained in the supernatant fraction, and the cAMP dependence remained unchanged. We attempted to alter either the level of activity or degree of cAMP stimulation in the crude sonicates or supernatant fraction by treating platelets with thrombin, 1 U/ml, before sonication. There was no observed change in total protein kinase activity or ratio of activity -cAMP/+cAMP despite the presence of the phosphodiesterase inhibitor 1-methyl-3-isobutylxanthine with either protein substrate (41 Endogenous phosphorylation of crude platelet extracts.
When the endogenous phosphorylation activities of sonicated platelets and the supernatant fraction of sonicated platelets were studied using higher specific activity [y-"P]ATP (200-1,000 cpm/pmol), we found no change in total incorporation of label into trichloroacetic acid-precipitable material with or without 1 U/ml bovine thrombin present during the labeling period. When the samples were electrophoresed on an SDS slab gel, an autoradiograph showed most of the label was contained in peak 7 and 9 proteins, and no significant change in labeling pattern was observed when thrombin was added during labeling. Likewise, addition of 1 AM cAMP in the presence of the phosphodiesterase inhibitor 1-methyl-3-isobutylxanthine with or without 1 U/ml thrombin showed no difference in incorporation of "PO4 into trichloroacetic-precipitable material. The (Pg) FIGURE 6 Effect of rabbit muscle regulatory subunit on the platelet cAMP-dependent and cAMP-independent enzymes in the presence and absence of cAMP. The assays were performed as described in Methods except that the enzymes were incubated with the indicated amount of regulatory subunit for 30 min at 0'C before initiating the protein kinase assay. Protamine was the substrate with the cAMP-independent enzyme and histone f2b was the substrate with the cAMP-dependent enzyme. (0) cAMIPdependent enzyme in the absence of cAMP; (0) cAMPdependent enzyme in the presence of cAMP; (A) and (A) cAMP-independent enzyme in the absence and presence of cAMP, respectively. cAMP-independent enzyme. Numerous attempts to stabilize the enzymes proved unsuccessful although they were more stable after concentration on small DEAE-cellulose columns (see Methods).
Characterization of platelet protein kinases with rabbit muscle proteins. Experiments using rabbit muscle regulatory subunit and rabbit muscle heatstable inhibitor were carried out to establish that the cAMP-dependent enzyme was a typical cAMPregulated protein kinase and also to determine whether the cAMP-independent enzyme was the free catalytic subunit of a cAMP-regulated holoenzyme. In the presence of the rabbit muscle regulatory subnuit, the cAMPdependent enzyme was inhibited in the absence of cAMP but was unaffected in the presence of cAMP as shown in Fig. 6 . This result suggests that this enzyme is a cAMPdependent holoenzyme. This conclusion was further supported by results shown in Fig. 7 , where inhibition by rabbit muscle heat-stable inhibitor in the presence and to some extent in the absence of cAMP is demonstrated.
In contrast, the cAMP-independent enzyme does not apparently correspond to the catalytic subunit of the cAMP-regulated enzyme. Thus, it is not inhibited by regulatory subunit (Fig. 6 ) nor is it inhibited by the heat-stable inhibitor (Fig. 7) . The Effect of thrombin on the activity of the platelet protein kinases. When we incubated both separated enzyme fractions with varying concentrations of thrombin (0.1-10 U/ml) for varying periods of time (1-60 min) at room temperature, we observed no alteration of activity or change in cAMP dependence when assayed with exogenous substrates in any of these experiments when comparing thrombin-treated to untreated enzyme.
Properties of platelet protein kinases. The platelet protein kinases were unlike in their lability upon heating of the DEAE-concentrated enzymes (6,000 U/ml) at 37°C. Thus, the cAMP-dependent enzyme lost 30% of its activity after 1 h while the cAMP-independent enzyme lost 85% of its activity. Both enzymes require Mg"+ for activity, and neither enzyme showed any activity when Ca"+ was the only divalent cation present. In the presence of 7 mM Mg"+ ions, calcium markedly inhibited protein kinase activity with 50% inhibition of activity of both enzymes occurring at 1-2 mM Ca".
The platelet protein kinase enzymes were also readily Thus, the lack of stimulation by cAMP of the cAMPindependent enzyme was not due to destruction of the cAMP by a phosphodiesterase present in the protein kinase fraction.
Endogenous phosphorylation using fractionated protein kinases. Since the two enzyme fractions were relatively crude preparations, we studied their endogenous phosphorylation with high specific activity [e--"P]ATP (200-1,000 cpm/pmol). The cAMP-dependent enzyme showed increased incorporation of label into trichloroacetic acid-precipitable material when cAMIP was added. When the reaction product was electrophoresed on an SDS polyacrylamide slab gel and an autoradiograph was obtained, cAMP-stimulated incorporation of label into a protein of mol wt 98,000 was seen. Incorporation of label into a protein that coelectrophoresed with peak 7 protein was also observed, and this incorporation was increased twofold when 2 gNM cAM1P was added (data not shown). This result is paradoxical in that the thrombin-induced phosphorylation reaction in intact platelets is inhibited by agents that increase intracellular cAMP. There was no "PO, label in the region of the gel corresponding to peak 9 protein. Whether this results from absence of substrate or inability of the enzyme to phosphorylate peak 9 protein could not be determined. When a similar experiment using the cAMP-independent enzyme was performed, there was no labeling of either peak 7 or peak 9 proteins. Again, it was not possible to determine whether this related to lack of substrates in the fraction or to specificity of the enzyme. These experiments indicate that the cAMP-dependent enzyme may act on peak There are many similarities between the characteristics of the platelet release reaction and phosphorylation of peak 7 and peak 9 proteins. The published time of 10-30 s for half-maximal thrombin-induced release (33, 38, 39) is similar to the observed time for halfmaximal thrombin-induced phosphorylation of protein peaks 7 and 9 (10-14 s). Likewise, the concentration of thrombin required for half-maximal release (5, 38, 39 ) is similar to the observed concentration of thrombin (0.25 U/ml) required for half-maximal phosphorylation of peak 7 and peak 9 proteins. DFP-treated thrombin, which binds normally to platelets without inducing the release reaction (3), does not induce peak 7 protein or peak 9 protein phosphorylation. The lectin E-PHA, which binds to the platelet surface, decreases adenylate cyclase activity, and causes the platelet release reaction in washed human platelets (14-33), induces peak 7 protein and peak 9 protein phosphorylation. Thrombin and E-PHA are presumably related in their mode of action on platelets since elevation of intracellular platelet cAMIP blocks their initiation of the release reaction (5, 33, 40) . We observed that PGE1 or DB-cAMP inhibited thrombin-induced phosphorylation of peak 7 and 9 proteins. These similarities between the platelet release reaction and phosphorylation of peak 7 and peak 9 suggest a relationship between the two phenomena. However, our data do not indicate whether peak 7 or peak 9 protein phosphorylation is part of the releaseinducing mechanism, a result of the release reaction, or a simultaneous but unrelated event.
In most cAMP-modulated systems an increase in protein phosphorylation follows activation of a cAMPdependent protein kinase by an increase in intracellular cAMP. However, in the intact platelet system the usual positive correlation between cAMNP levels and protein phosphorylation does not appear to hold since an increase in intracellular cAMP blocks the thrombininduced peak 7 and peak 9 protein phosphorylation. Several examples of an inverse correlation between a change in cAMP concentration and protein phosphorylation have been described in the literature (7) (8) (9) (10) (42) (43) (44) (45) . In toad bladder mucosa it was observed that antidiuretic hormone induced a decrease in phosphorylation of membrane and soluble proteins in association with an increase in intracellular cAMP (7) (8) (9) . In that system, a decrease in phosphorylation of a specific membrane protein appeared to be the result of both the inhibition of protein kinase activity and the stimulation of phosphoprotein phosphatase activity. Our results do not distinguish between thrombin-induced stimulation of protein kinase activity and thrombin-induced inhibition of phosphoprotein phosphatase activity.
Other mechanisms unrelated to cAMP could explain the thrombin-induced phosphorylation of peak 7 and 9 proteins. First, thrombin might alter the activity of an as yet undescribed guanosine 3',5'-cyclic monophosphatedependent protein kinase or phosphatase. Second, thrombin could rapidly increase the specific activity of the ATP available to the protein kinase(s) responsible for peak 7 and peak 9 protein phosphorylation. This latter suggestion would be difficult to test since changes in the specific activity of total platelet ATP may not reflect changes in the specific activity of the ATP available to the kinase. Lastly, we observed that there was inhibition of the two protein kinase enzymes by Ca"+ in the presence of Mg"+ and the complete lack of activity when Mg++ was absent and Ca++ was present. Thus, the secretion of Ca++ induced by thrombin during the release reaction (38) could remove the inhibition of the protein kinase(s) responsible for peaks 7 and 9 protein phosphorylation. Possibly the inhibition of phosphorylation by agents that elevate cAMP is due to inhibition of Ca++ release by cAMP.
We have shown that in the presence of [y-"2P]ATP, disrupted platelets as well as the supernatant fraction of disrupted platelets phosphorylate endogenous platelet proteins that co-electrophorese with peak 7 and 9 proteins. In contrast to the intact platelet system, this phosphorylation is not affected by cAMP or thrombin.
We cannot easily explain the difference observed in the effect of thrombin and cAMP on protein phosphorylation in intact platelets versus platelet homogenates. However, our results do suggest that the normal control mechanisms of platelet protein kinase and/or phosphoprotein phosphatase activity are disrupted during cell lysis. This suggestion is consistent with earlier observations which indicated that intact platelets were necessary to observe a variety of physiological effects of thrombin (5) .
We have observed only minimal phosphorylation of peak 7 (46) . They suggested that thrombin decreases platelet protein phosphorylation of the 44,000-mol wt band and that cAMP increases platelet membrane phosphorylation. In contrast, Steiner has presented preliminary data suggesting that thrombin increases phosphate incorporation into isolated platelet membranes in the presence of ['y-"P]ATP (47) . Insufficient details are available in these reports to make direct comparisons to our results.
Protein kinases can be divided into three major groups (6): (a) cAMP-regulated, including free catalytic subunit and cAMP-stimulated holoenzyme; (b) cAMPindependent, which includes such enzymes as phosphorylase b kinase (48) , histone kinase HK2 (49), phosvitin kinase (50), casein kinase (51), and chromatin protein kinase (52) ; and (c) the not-so-well characterized cAMP-inhibited enzymes (7) (8) (9) (10) (42) (43) (44) (45) primarily that of the cAMP-independent enzyme. Thus, the protein kinase activity of the crude fractions when assayed with histone f2b as substrate was stimulated by cAMP while the activity when assayed with protamine as substrate was only slightly affected by cAMP.
The substrates of the two enzymes in intact platelets have not been determined since the enzymes have not been isolated from all potential substrates. The cAMPdependent enzyme fraction apparently contained one of the substrates of most interest, i.e., peak 7 protein. Phosphorylation of this protein was stimulated by cAMP but not by thrombin. We have thus shown that this enzyme fraction is capable of phosphorylating a protein that co-electrophoreses with peak 7 protein, but whether it actually is responsible for the thrombin-induced increase in phosphorylation of peak 7 protein observed in intact platelets is not known.
The fact that phosphorylation of peak 7 protein is stimulated by cAMP with the fractionated enzyme while cAMP has no effect on peak 7 protein phosphorylation in crude sonicates as well as the fact that agents that elevate the intracellular cAMP levels clearly inhibit thrombin-induced phosphorylation with intact 'PO4-loaded platelets indicates that cAMP regulation of a protein kinase is not the sole control mechanism for protein phosphorylation in intact platelets.
The identities of peak 7 and peak 9 protein are not known. However, peak 7 protein migrates with actin in the darkest Coomassie Blue staining region on SDS polyacrylamide gel electrophoresis of platelets (54), while a light chain of platelet myosin has been demonstrated to migrate at a molecular weight similar to peak 9 protein (55, 56) . Preliminary experiments have suggested that peak 7 protein is not actin but that peak 9 protein may be the light chain of platelet myosin. Purification of peak 7 and 9 proteins will help to clarify their identity and location, their interaction with the platelet protein kinases, and their role in the platelet release reaction.
